Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2425721Generated: October 29, 2026

1-(2-Methanesulfonylethyl)piperazine dihydrochloride → HCID 86602332, compound

https://huagongshe.com/reaction/2425721

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(2-Methanesulfonylethyl)piperazine dihydrochlorideHCID 17749885—
ReactantHCID 86602331HCID 86602331—
ProductHCID 86602332HCID 86602332300.4%

Reaction Steps

4,5-Bis-(4-chloro-phenyl)-2-[2-ethoxy-4-(2-methoxy-1,1-dimethyl-ethyl)-phenyl]-4,5-dihydro-imidazole-1-carbonyl chloride (60 mg, 0.107 mmol, example 153) was reacted with 1-(2-methanesulfonyl-ethyl)piperazine dihydrochloride (42.5 mg, 0.161 mmol, example 17) using the procedure described in example 25 to give 4,5-bis-(4-chloro-phenyl)-2-[2-ethoxy-4-(2-methoxy-1,1-dimethyl-ethyl)-phenyl]-4,5-dihydro-imidazol-1-yl}-[4-(2-methanesulfonyl-ethyl)-piperazin-1-yl]-methanone (70.8 mg) as white solids. The enantiomers were separated by chiral chromatography (Diacel ChiralPak OD, eluting with 40/60 hexane/ethanol). The first peak coming off the column is the desired {(4S,5R)-4,5-bis-(4-chloro-phenyl)-2-[2-ethoxy-4-(2-methoxy-1,1-dimethyl-ethyl)-phenyl]-4,5-dihydro-imidazol-1-yl}-[4-(2-methanesulfonyl-ethyl)-piperazin-1-yl]-methanone (32.1 mg, white solids). HR-MS (ES, m/z): observed 715.2485, calculated for C36H45Cl2N4O5S [(M+H)+] 715.2482.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07964724B2
Source datasetuspto-grants-2011_06
ORD IDord-bad341aeff22445cab0646eab44875e8
Source noteuspto-grants-2011_06